Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADDLE: Ranibizumab in RVO with/without PVD
NCT00831350Phase 2Completed
- Sponsor
- Barnes Retina Institute
- Start
- Apr 2009
- Primary completion
- Jul 2011
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in retinal vein occlusion (RVO), sponsored by Barnes Retina Institute. Started Apr 2009; status: completed.
02
Drugs
ranibizumab
03
Conditions
retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT00831350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831350.